Ir para conteúdo

Cuidados Intensivos

Gestão e Otimização da Hemostase

Agentes Antifibrinolíticos

Alternatives to allogeneic platelet transfusion. (abre uma nova janela)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Fonte‎: Br J Haematol 2016;175(3):381-92.

Indexado‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (abre uma nova janela)

Tranexamic acid: less bleeding and less thrombosis? (abre uma nova janela)

Godier A, Roberts I, Hunt BJ.

Fonte‎: Crit Care 2012;16(3):135.

Indexado‎: PubMed 22748073

DOI‎: 10.1186/cc11374

https://www.ncbi.nlm.nih.gov/pubmed/22748073 (abre uma nova janela)

Tranexamic acid for reducing mortality in emergency and urgent surgery. (abre uma nova janela)

Perel P, Ker K, Morales Uribe CH, Roberts I

Fonte‎: Cochrane Database Syst Rev 2013;(1):CD010245.

Indexado‎: PubMed 23440847

DOI‎: 10.1002/14651858.CD010245.pub2

https://www.ncbi.nlm.nih.gov/pubmed/23440847 (abre uma nova janela)

The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. (abre uma nova janela)

Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T; CRASH-2 collaborators.

Fonte‎: Lancet 2011;377(9771):1096-101, 1101.e1-2.

Indexado‎: PubMed 21439633

DOI‎: 10.1016/S0140-6736(11)60278-X

https://www.ncbi.nlm.nih.gov/pubmed/21439633 (abre uma nova janela)

Antifibrinolytic drugs for acute traumatic injury. (abre uma nova janela)

Roberts I, Shakur H, Ker K, Coats T; CRASH‐2 Trial collaborators.

Fonte‎: Cochrane Database Syst Rev 2011;(1):CD004896.

Indexado‎: PubMed 21249666

DOI‎: 10.1002/14651858.CD004896.pub3

https://www.ncbi.nlm.nih.gov/pubmed/21249666 (abre uma nova janela)

Use of tranexamic acid to reduce bleeding in burns surgery. (abre uma nova janela)

Tang YM, Chapman TW, Brooks P

Fonte‎: J Plast Reconstr Aesthet Surg 2012;65(5):684-6.

Indexado‎: PubMed 21983540

DOI‎: 10.1016/j.bjps.2011.09.028

https://www.ncbi.nlm.nih.gov/pubmed/21983540 (abre uma nova janela)

Tranexamic acid reduced blood transfusions in acute burn surgery: a retrospective case-controlled trial. (abre uma nova janela)

Tapking C, Hundeshagen G, Kirchner M, Fischer S, Kneser U, Bliesener B

Fonte‎: Burns. 2022;48(3):522-28.

Indexado‎: PubMed 35339324

DOI‎: 10.1016/j.burns.2022.03.002

https://pubmed.ncbi.nlm.nih.gov/35339324/ (abre uma nova janela)

Fator VII Recombinante Ativado (rFVIIa)

Salvage use of activated recombinant factor VII in the management of refractory bleeding following cardiac surgery. (abre uma nova janela)

Barua A, Rao VP, Ramesh B, Barua B, El-Shafei H.

Fonte‎: J Blood Med 2011;2:131-4.

Indexado‎: PubMed 22287872

DOI‎: 10.2147/JBM.S21609

https://www.ncbi.nlm.nih.gov/pubmed/22287872 (abre uma nova janela)

The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage. (abre uma nova janela)

Boffard KD, Choong PI, Kluger Y, Riou B, Rizoli SB, Rossaint R, Warren B; NovoSeven Trauma Study Group.

Fonte‎: Transfusion 2009;49 Suppl 5:240S-7S.

Indexado‎: PubMed 19954486

DOI‎: 10.1111/j.1537-2995.2008.01987.x

https://www.ncbi.nlm.nih.gov/pubmed/19954486 (abre uma nova janela)

Results of the control trial: efficacy and safety of recombinant activated factor VII in the management of refractory traumatic hemorrhage. (abre uma nova janela)

Hauser CJ, Boffard K, Dutton R, Bernard GR, Croce MA, Holcomb JB, Leppaniemi A, Parr M, Vincent JL, Tortella BJ, Dimsits J, Bouillon B; CONTROL Study Group.

Fonte‎: J Trauma 2010;69(3):489-500.

Indexado‎: PubMed 20838118

DOI‎: 10.1097/TA.0b013e3181edf36e

https://www.ncbi.nlm.nih.gov/pubmed/20838118 (abre uma nova janela)

Use of recombinant activated factor VII in Jehovah's Witness patients with critical bleeding. (abre uma nova janela)

Kandane-Rathnayake RK, Isbister JP, Zatta AJ, Aoki NJ, Cameron P, Phillips LE; Australian and New Zealand Haemostasis Registry Steering Committee

Fonte‎: ANZ J Surg 2013;83(3):155-60.

Indexado‎: PubMed 23035873

DOI‎: 10.1111/j.1445-2197.2012.06285.x

https://www.ncbi.nlm.nih.gov/pubmed/23035873 (abre uma nova janela)

Recombinant factor VIIa in trauma patients with the 'triad of death.' (abre uma nova janela)

Mitra B, Cameron PA, Parr MJ, Phillips L.

Fonte‎: Injury 2012;43(9):1409-14.

Indexado‎: PubMed 21345431

DOI‎: 10.1016/j.injury.2011.01.033

https://www.ncbi.nlm.nih.gov/pubmed/21345431 (abre uma nova janela)

Low-dose recombinant factor VIIa for trauma patients with coagulopathy. (abre uma nova janela)

Stein DM, Dutton RP, Hess JR, Scalea TM.

Fonte‎: Injury 2008;39(9):1054-61.

Indexado‎: PubMed 18656871

DOI‎: 10.1016/j.injury.2008.03.032

https://www.ncbi.nlm.nih.gov/pubmed/18656871 (abre uma nova janela)

Concentrados de Fatores de Coagulação

Alternatives to allogeneic platelet transfusion. (abre uma nova janela)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Fonte‎: Br J Haematol 2016;175(3):381-92.

Indexado‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (abre uma nova janela)

Plasma fibrinogen level on admission to the intensive care unit is a powerful predictor of postoperative bleeding after cardiac surgery with cardiopulmonary bypass. (abre uma nova janela)

Kindo M, Hoang Minh T, Gerelli S, Perrier S, Meyer N, Schaeffer M, Bentz J, Announe T, Mommerot A, Collange O, Pottecher J, Cristinar M, Thiranos JC, Gros H, Mertes PM, Billaud P, Mazzucotelli JP

Fonte‎: Thromb Res 2014;134(2):360-8.

Indexado‎: PubMed 24857189

DOI‎: 10.1016/j.thromres.2014.05.008

https://www.ncbi.nlm.nih.gov/pubmed/24857189 (abre uma nova janela)

Strategies to reduce the use of blood products: a European perspective. (abre uma nova janela)

Theusinger OM, Felix C, Spahn DR.

Fonte‎: Curr Opin Anaesthesiol 2012;25(1):59-65.

Indexado‎: PubMed 22113184

DOI‎: 10.1097/ACO.0b013e32834dec98

https://www.ncbi.nlm.nih.gov/pubmed/22113184 (abre uma nova janela)

Desmopressina

Desmopressin reduces transfusion needs after surgery: a meta-analysis of randomized clinical trials. (abre uma nova janela)

Crescenzi G, Landoni G, Biondi-Zoccai G, Pappalardo F, Nuzzi M, Bignami E, Fochi O, Maj G, Calabrò MG, Ranucci M, Zangrillo A

Fonte‎: Anesthesiology 2008;109(6):1063-76.

Indexado‎: PubMed 19034103

DOI‎: 10.1097/ALN.0b013e31818db18b

https://www.ncbi.nlm.nih.gov/pubmed/19034103 (abre uma nova janela)

Alternatives to allogeneic platelet transfusion. (abre uma nova janela)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Fonte‎: Br J Haematol 2016;175(3):381-92.

Indexado‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (abre uma nova janela)

Desmopressin in treatment of haematological disorders and in prevention of surgical bleeding. (abre uma nova janela)

Svensson PJ, Bergqvist PB, Juul KV, Berntorp E

Fonte‎: Blood Rev 2014;28(3):95-102.

Indexado‎: PubMed 24703870

DOI‎: 10.1016/j.blre.2014.03.001

https://www.ncbi.nlm.nih.gov/pubmed/24703870 (abre uma nova janela)

Outros Agentes

Vitamin K deficiency and D-dimer levels in the intensive care unit: a prospective cohort study. (abre uma nova janela)

Crowther MA, McDonald E, Johnston M, Cook D

Fonte‎: Blood Coagul Fibrinolysis 2002;13(1):49-52.

Indexado‎: PubMed 11994567

DOI‎: 10.1097/00001721-200201000-00007

https://www.ncbi.nlm.nih.gov/pubmed/11994567 (abre uma nova janela)

Agentes Hemostáticos de Uso Tópico

The use of fibrin sealant in burn operations. (abre uma nova janela)

Foster K

Fonte‎: Surgery 2007;142(4 Suppl):S50-4.

Indexado‎: PubMed 18019939

DOI‎: 10.1016/j.surg.2007.06.026

https://www.ncbi.nlm.nih.gov/pubmed/18019939 (abre uma nova janela)

Use of fibrin sealant in thermal injury. (abre uma nova janela)

McGill V, Kowal-Vern A, Lee M, Greenhalgh D, Gomperts E, Bray G, Gamelli R

Fonte‎: J Burn Care Rehabil 1997;18(5):429-34.

Indexado‎: PubMed 9313125

DOI‎: 10.1097/00004630-199709000-00011

https://www.ncbi.nlm.nih.gov/pubmed/9313125 (abre uma nova janela)

Testes Viscoelásticos para Identificar Hemorragia Cirúrgica ou Coagulopatia

Perioperative treatment algorithm for bleeding burn patients reduces allogeneic blood product requirements. (abre uma nova janela)

Schaden E, Kimberger O, Kraincuk P, Baron DM, Metnitz PG, Kozek-Langenecker S

Fonte‎: Br J Anaesth 2012;109(3):376-81.

Indexado‎: PubMed 22719014

DOI‎: 10.1093/bja/aes186

https://www.ncbi.nlm.nih.gov/pubmed/22719014 (abre uma nova janela)

Transfusion in trauma: why and how should we change our current practice? (abre uma nova janela)

Theusinger OM, Spahn DR, Ganter MT.

Fonte‎: Curr Opin Anaesthesiol 2009;22(2):305-12.

Indexado‎: PubMed 19390257

DOI‎: 10.1097/ACO.0b013e3283212c7c

https://www.ncbi.nlm.nih.gov/pubmed/19390257 (abre uma nova janela)

Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis. (abre uma nova janela)

Whiting P, Al M, Westwood M, Ramos IC, Ryder S, Armstrong N, Misso K, Ross J, Severens J, Kleijnen J

Fonte‎: Health Technol Assess 2015;19(58):1-228.

Indexado‎: PubMed 26215747

DOI‎: 10.3310/hta19580

https://www.ncbi.nlm.nih.gov/pubmed/26215747 (abre uma nova janela)